Workflow
Clinical Development
icon
Search documents
Apimeds Pharmaceuticals US Inc(APUS) - Prospectus(update)
2024-12-20 11:12
As filed with the Securities and Exchange Commission on December 19, 2024. Registration No. 333-282324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________ AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________________ APIMEDS PHARMACEUTICALS US, INC. (Exact name of registrant as specified in its charter) __________________________________________ | Delaware | 2834 | 85-1099700 | | - ...
Apimeds Pharmaceuticals US Inc(APUS) - Prospectus(update)
2024-11-08 11:12
As filed with the Securities and Exchange Commission on November 7, 2024. Registration No. 333-282324 (Exact name of registrant as specified in its charter) __________________________________________ | Delaware | 2834 | 85-1099700 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or organization) | Classification Code Number) | Identification Number) | Apimeds Pharmaceuticals US, Inc. 2 East Broad Street 2 nd Floor Hopewell, NJ 08425 ...
Moleculin(MBRX) - Prospectus(update)
2024-08-15 15:21
Table of Contents As filed with the Securities and Exchange Commission on August 15, 2024. Registration No. 333-280951 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Moleculin Biotech, Inc. (Exact name of registrant as specified in its charter) | Delaware | 2834 | 47-4671997 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or ...
Moleculin(MBRX) - Prospectus(update)
2024-08-15 01:57
As filed with the Securities and Exchange Commission on August 14, 2024. | Delaware | 2834 | 47-4671997 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or organization) | Classification Code Number) | Identification Number) | | | 5300 Memorial Drive, Suite 950 | | | | Houston, Texas 77007 | | | | (713) 300-5160 | | Registration No. 333-280951 (Address, including zip code, and telephone number, including area code, of registrant's pr ...
Moleculin(MBRX) - Prospectus(update)
2024-07-30 11:00
As filed with the Securities and Exchange Commission on July 30, 2024. (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Registration No. 333-280951 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Moleculin Biotech, Inc. (Exact name of registrant as specified in its charter) | Delaware | 2834 | 47-4671997 | | --- | --- | --- | | (State or o ...
GRI Bio(GRI) - Prospectus(update)
2024-06-26 20:03
As filed with the Securities and Exchange Commission on June 26, 2024. Registration No. 333-280323 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GRI BIO, INC. (Exact name of registrant as specified in its charter) (Primary Standard Industrial Classification Code Number) Delaware 2834 82-4369909 (I.R.S. Employer Identification Number) (State or other jurisdiction of incorporation or organization) 222 ...
VALLON PHARMACEU(VLON) - Prospectus(update)
2024-06-26 01:55
(Primary Standard Industrial Classification Code Number) As filed with the Securities and Exchange Commission on June 25, 2024. Registration No. 333-280323 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GRI BIO, INC. (Exact name of registrant as specified in its charter) Delaware 2834 82-4369909 (I.R.S. Employer (State or other jurisdiction of incorporation or organization) 2223 Avenida de la Playa, ...
60 Degrees Pharmaceuticals(SXTP) - Prospectus
2024-01-22 20:57
As filed with the U.S. Securities and Exchange Commission on January 22, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 60 DEGREES PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 2834 45-2406880 (I.R.S. Employer Identification No.) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) 1025 ...
GRI Bio(GRI) - Prospectus
2023-12-21 22:13
As filed with the Securities and Exchange Commission on December 21, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GRI BIO, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 82-4369909 (I.R.S. Employer Identification Number) 2223 Avenida de la Playa ...
MEDTECH ACQUISIT(MTAC) - Prospectus
2023-12-15 21:10
FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Table of Contents As filed with the U.S. Securities and Exchange Commission on December 15, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Mary Szela Chief Executive Officer 6272 W. 91st Ave. Westminster, Colorado 80031 (888) 321-5212 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: TRISALUS LIFE SCIENCES, INC. (Exact name of regis ...